enzalutamide
pfizer,astellas
['enzamet', 'lba5004']
ian davis updates os outcomes in enzamet trial of enzalutamide in mhspc. enzalutamide added to testosterone suppression for mhspc, with improvements in os. best benefits for lv mhspc, but also benefits for hv mhspc. watch on demand at #asco22 abstract lba5004 #meded 
Independent and international experts in GenitoUrinary (GU) oncology. Part of https://t.co/QAbKORwRcf